sotorasib
amgen
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'sotorasib']
avm: scarlet study wjog14821l
single arm ph2 sotorasib + chemo in kras g12c nonsquamous mnsclc n=30, chemo &amp; kras inhibitor naive 1ry endpoint orr: 88.9%
no diff in orr by pd-l1 expression
mpfs and mos nr but limited f/u at analysis of only 4 mo
#lcsm #asco23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.